Final ID: HTN11
Zhang Shuqi, Freburger Janet, Trogdon Justin, Patterson Charity, Wen Molly, Jones Sara
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Monthly or Quarterly Subcutaneous Administration of the Interleukin-6 Inhibitor Pacibekitug in Patients With Elevated High-Sensitivity C-Reactive Protein and Chronic Kidney Disease: 90-Day Analyses from TRANQUILITYPergola Pablo, Szarek Michael, Zayed Hany, Hemani Famina, Degoma Emil, Andorfer Cathy, Walsh John, Ridker Paul, Bhatt Deepak